Striking the Balance Between Surgical and Medical Topics | ASRS 2025
There will be a greater focus on surgical topics at the 2025 meeting of the American Society of Retina Specialists, compared with previous years, which reflects the need for balance within the industry, according to Gaurav K. Shah, M.D., program chair of ASRS 2025.
At the 2025 meeting of the American Society of Retina Specialists, there will be a better balance between surgical talks and pharmacological talks, compared with years past, according to Gaurav K. Shah, M.D., program chair of ASRS 2025. Shah cited the overshadowing of surgical interventions by pharmaceutical interventions.
“We have about 47% surgical and 53% medical talks planned,” Shah said in a recent video interview with Managed Healthcare Executive. “In the past, we were about 20% and 80%. We have ramped that up to make sure that we treat, as they say in Washington, both aisles. We need to be balanced.”
Gaurav K. Shah, M.D.
ASRS 2025 takes place from July 30 to August 2, 2025, at the Long Beach Convention Center in Long Beach, California.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
First-in-Class Therapy for Diabetic Retinopathy Shows Six-Month Benefit | ASRS 2025
July 31st 2025PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block endothelin signaling to increase ocular blood flow and prevent vision loss.
Read More
Changes to Susvimo Port Delivery System Explained | ASRS 2024
July 31st 2025Dante J. Pieramici, M.D., of the California Retina Research Foundation, explains changes made to the Susvimo port delivery system that are designed. to prevent the septum dislodgment that led to Genentech pulling the product off the market.
Read More
Results from retrospective real-world studies presented at American Society of Retina Specialists annual meetiing put the risk of retinal vasculitis from Syfovre at 1 in 1,330 patients. But other results presented at the meeting supplied evidence that Syfovre fends off vision loss caused by geographic atrophy, an advanced form of dry age-related macular degeneration.
Read More
